Retroviral vaccines: Challenges for the developing world

被引:10
作者
Essex, M
机构
关键词
D O I
10.1089/aid.1996.12.361
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:361 / 363
页数:3
相关论文
共 26 条
[1]  
ASJO B, 1986, LANCET, V2, P660
[2]   PATHOGENICITY OF LIVE, ATTENUATED SIV AFTER MUCOSAL INFECTION OF NEONATAL MACAQUES [J].
BABA, TW ;
JEONG, YS ;
PENNINCK, D ;
BRONSON, R ;
GREENE, MF ;
RUPRECHT, RM .
SCIENCE, 1995, 267 (5205) :1820-1825
[3]   HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VARIANTS WITH INCREASED REPLICATIVE CAPACITY DEVELOP DURING THE ASYMPTOMATIC STAGE BEFORE DISEASE PROGRESSION [J].
CONNOR, RI ;
HO, DD .
JOURNAL OF VIROLOGY, 1994, 68 (07) :4400-4408
[4]   PROTECTIVE EFFECTS OF A LIVE ATTENUATED SIV VACCINE WITH A DELETION IN THE NEF GENE [J].
DANIEL, MD ;
KIRCHHOFF, F ;
CZAJAK, SC ;
SEHGAL, PK ;
DESROSIERS, RC .
SCIENCE, 1992, 258 (5090) :1938-1941
[5]   SIMIAN IMMUNODEFICIENCY VIRUS IN PEOPLE [J].
ESSEX, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (03) :209-210
[6]  
ESSEX M, 1994, TECHNOL REV, V97, P23
[7]  
Essex M, 1994, Textbook of AIDS medicine, P873
[8]   IDENTIFICATION OF THE ENVELOPE V3 LOOP AS THE PRIMARY DETERMINANT OF CELL TROPISM IN HIV-1 [J].
HWANG, SS ;
BOYLE, TJ ;
LYERLY, HK ;
CULLEN, BR .
SCIENCE, 1991, 253 (5015) :71-74
[9]  
JAIN MK, 1994, AIDS S2, V8, P561
[10]  
KUNANUSONT C, 1995, LANCET, V345, P1078, DOI 10.1016/S0140-6736(95)90818-8